Targeted Medical Pharma Company Profile (OTCMKTS:TRGM)

About Targeted Medical Pharma (OTCMKTS:TRGM)

Targeted Medical Pharma logoTargeted Medical Pharma, Inc. (TMP), also doing business as Physician Therapeutics (PTL), is a specialty pharmaceutical company that develops and commercializes amino acid-based medications. The Company develops and distributes a line of amino acid-based medical food products, dietary supplements and generic drugs to physicians, pharmacies and patients throughout the United States and abroad. The Company operates through TMP, Complete Claims Processing Inc. (CCPI) and Amino Nutritionals segments. TMP develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers. CCPI segment provides point-of-care dispensing solutions, and billing and collections services. Amino Nutritionals segment develops and distributes amino acid-based dietary supplements directly to consumers. Its products and services include Medical Foods, Medical foods and generic pharmaceuticals, and Billing and Collections.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: $180,000.00
  • Outstanding Shares: 30,185,000
Average Prices:
  • 52 Week Range: $0.01 - $0.03
  • Trailing P/E Ratio:
  • P/E Growth:
Sales & Book Value:
  • Annual Revenue: $5.26 million
  • Price / Sales: 0.03
  • Book Value: ($0.47) per share
  • Price / Book: -0.01
  • EBIDTA: ($1,660,000.00)
  • Average Volume: 1,438 shs.
  • Beta: -2.76

Frequently Asked Questions for Targeted Medical Pharma (OTCMKTS:TRGM)

What is Targeted Medical Pharma's stock symbol?

Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM."

Who are some of Targeted Medical Pharma's key competitors?

Who are Targeted Medical Pharma's key executives?

Targeted Medical Pharma's management team includes the folowing people:

  • Kim Giffoni, Chief Executive Officer, Director
  • William B. Horne, Chief Financial Officer
  • Douglas P. Gintz, Chief Technology Officer
  • David Samuel Silver M.D., Chief Medical Officer, Director
  • Kerry N. Weems, Non-Executive Chairman of the Board, Director
  • Maurice J. DeWald, Independent Director
  • Thomas Wenkart, Independent Director

How do I buy Targeted Medical Pharma stock?

Shares of Targeted Medical Pharma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Targeted Medical Pharma's stock price today?

One share of Targeted Medical Pharma stock can currently be purchased for approximately $0.01.

MarketBeat Community Rating for Targeted Medical Pharma (OTCMKTS TRGM)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  14
MarketBeat's community ratings are surveys of what our community members think about Targeted Medical Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Targeted Medical Pharma (OTCMKTS:TRGM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Targeted Medical Pharma (OTCMKTS:TRGM)
No equities research coverage for this company has been tracked by


Earnings History for Targeted Medical Pharma (OTCMKTS:TRGM)
No earnings announcements for this company have been tracked by


Earnings Estimates for Targeted Medical Pharma (OTCMKTS:TRGM)

No earnings estimates for this company have been tracked by


Dividend History for Targeted Medical Pharma (OTCMKTS:TRGM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Targeted Medical Pharma (OTCMKTS:TRGM)
Insider Ownership Percentage: 69.20%
Insider Trades by Quarter for Targeted Medical Pharma (OTCMKTS:TRGM)
Insider Trades by Quarter for Targeted Medical Pharma (OTCMKTS:TRGM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/24/2015Kim GiffoniCEOSell8,580$0.02$171.60View SEC Filing  
5/28/2014William ShellCEOSell2,000$0.60$1,200.00View SEC Filing  
5/27/2014William ShellCEOSell3,000$0.65$1,950.00View SEC Filing  
4/10/2014William ShellCEOSell150,000$0.60$90,000.00View SEC Filing  
4/9/2014Kim GiffoniEVPBuy5,000$0.83$4,150.00View SEC Filing  
12/12/2013Kim GiffoniEVPBuy1,000$0.90$900.00View SEC Filing  
12/11/2013Kim GiffoniEVPBuy11,980$0.88$10,542.40View SEC Filing  
12/2/2013Kim GiffoniEVPBuy4,800$1.06$5,088.00View SEC Filing  
9/13/2013William ShellDirectorSell2,000$0.84$1,680.00View SEC Filing  
6/20/2013William ShellDirectorBuy28,100$1.15$32,315.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Targeted Medical Pharma (OTCMKTS:TRGM)
Latest Headlines for Targeted Medical Pharma (OTCMKTS:TRGM)



Targeted Medical Pharma (TRGM) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by Staff